ZURICH, Switzerland — November 12, 2026 — A scientific breakthrough from Switzerland could give forensic investigators more time to detect a drug commonly associated with drink-spiking and drug-facilitated sexual assault.
Researchers at the University of Zurich have evaluated a new biomarker that can reveal previous exposure to gamma-hydroxybutyrate (GHB), commonly known as a date-rape drug, through urine testing for up to 72 hours after ingestion.
The discovery could address one of the biggest challenges in investigating suspected drug-facilitated crimes: GHB disappears from the body relatively quickly, often leaving investigators with only a short window to collect useful toxicological evidence.
Under conventional testing, GHB is generally detectable for approximately six hours in blood and 12 hours in urine.
The newly evaluated biomarker, called GHB-pentose, can remain detectable considerably longer, potentially giving forensic laboratories additional opportunities to identify previous exposure even after conventional tests no longer detect the original substance.
The findings were reported by the University of Zurich on November 10 and published in the peer-reviewed scientific journal Drug Testing and Analysis on November 5.
The research could have important implications for sexual assault investigations, robbery cases and other suspected incidents involving the covert administration of incapacitating substances.
But while the discovery is promising, researchers caution that it is not a guaranteed test for proving drug-facilitated assault. Further validation is still necessary to establish its diagnostic reliability and detection limits in individual cases.
New GHB-Pentose Biomarker Could Extend Detection Window to 72 Hours
The breakthrough centers on GHB-pentose, a compound formed when GHB interacts with a sugar in the body.
Researchers believe the sugar involved is ribose, although the exact chemical structure has not yet been conclusively established.
A research team led by Andrea Steuer of the University of Zurich’s Institute of Forensic Medicine first identified the promising biomarker in 2021.
Unlike GHB itself, which is rapidly eliminated from the body, GHB-pentose remains detectable in urine for a longer period following ingestion.
A controlled study published in 2025 demonstrated that the biomarker could remain detectable for up to three days after GHB exposure.
The latest research goes further by examining whether the discovery can be useful in actual forensic investigations rather than relying exclusively on controlled experimental conditions.
That distinction is important because real-world investigations involve different circumstances, collection times and biological conditions.
The latest findings provide an encouraging indication that the extended detection window can also be relevant in forensic practice.
Researchers Examined 2,414 Urine Samples From Real Forensic Cases
For the latest study, researchers examined 2,414 anonymized urine samples collected from actual forensic cases between 2024 and 2026.
The samples were analyzed using two independent mass spectrometry methods commonly used in forensic toxicology.
One important finding involved 21 urine samples from living individuals that had already tested positive for GHB.
GHB-pentose was also detected in all 21 samples.
Researchers then identified another 14 samples that offered particularly important evidence.
In these cases, the measured GHB concentrations were below the established testing threshold, but the GHB-pentose biomarker remained detectable.
In eight of those 14 cases, information contained in the forensic records supported the suspicion that GHB had previously been consumed or administered.
Three cases involved suspected criminal offenses:
- Two suspected robberies.
- One alleged sexual assault.
In these incidents, urine samples were collected approximately 13 to 16 hours after the reported events.
The detection of GHB-pentose despite the low measured GHB levels suggests that the biomarker could help identify previous exposure after the conventional detection window has passed.
For investigators, that could provide another valuable piece of forensic evidence when reconstructing what happened.
However, the findings do not mean that every person exposed to GHB will test positive for the biomarker for exactly 72 hours.
The three-day detection period comes from earlier controlled research, while the latest forensic study provides real-case evidence supporting the usefulness of the biomarker beyond the usual detection window.
Why GHB Is Difficult to Detect in Suspected Drink-Spiking Cases
GHB is a substance that can produce powerful effects on the central nervous system.
It can be consumed voluntarily as a recreational substance or secretly administered to another person.
When used without someone’s knowledge, it can cause severe drowsiness, impaired consciousness, confusion and memory loss.
At higher exposures, it can lead to unconsciousness and potentially life-threatening respiratory and cardiovascular complications.
One reason GHB is particularly challenging in forensic investigations is how quickly the body processes and eliminates it.
According to the University of Zurich, conventional detection generally lasts around:
- Six hours in blood.
- Twelve hours in urine.
After that period, detecting the original substance becomes significantly more difficult.
GHB also occurs naturally in small quantities within the human body. It can even be produced after death, creating additional challenges when investigators are determining whether an individual consumed the substance before dying.
These characteristics can complicate forensic interpretation, particularly when victims cannot immediately explain what happened.
Some individuals may only recognize that something is wrong after waking up with confusion, unusual physical symptoms or gaps in their memory.
That is why researchers have been searching for more reliable indicators of previous GHB exposure.
Could the Discovery Help Sexual Assault Victims Obtain Stronger Evidence?
One of the most important potential applications involves investigations into drug-facilitated sexual assault.
These cases can be particularly difficult to investigate because victims may be unconscious, disoriented or unable to remember portions of the incident.
In some situations, individuals may not realize that they were drugged until several hours after the suspected event.
By then, conventional toxicological testing may no longer detect GHB.
The new biomarker could help address part of that problem.
If forensic laboratories can identify GHB-pentose after the original drug has fallen below conventional detection limits, investigators may have additional evidence to consider when examining a suspected crime.
The three suspected criminal cases identified in the Swiss research demonstrate why the discovery matters.
One involved an alleged sexual assault in which urine was collected 13 to 16 hours after the incident.
The biomarker was still detected even though the measured GHB concentration was below the testing threshold.
Nevertheless, detecting GHB-pentose does not independently establish that a sexual assault occurred, identify who administered the substance or determine whether an individual consented to sexual activity.
It is a potential forensic indicator of previous GHB exposure, not a complete criminal investigation.
Evidence must still be evaluated alongside witness statements, medical findings, other forensic samples and the circumstances of each case.
University of Zurich Says the Method Can Be Integrated Into Existing Laboratories
Another important aspect of the discovery is that the method does not necessarily require laboratories to build an entirely new testing infrastructure.
Researchers demonstrated that GHB-pentose could be detected using two different analytical methods already used in forensic toxicology.
This could make the technique easier to incorporate into established laboratory workflows.
The University of Zurich also reported that its Institute of Forensic Medicine has already incorporated GHB-pentose testing into its routine laboratory procedures when GHB administration is suspected.
However, an important limitation remains.
A commercially available reference standard for the biomarker is not yet available.
Reference standards help laboratories establish and verify the identity and concentration of substances during analytical testing.
The absence of such a commercially available standard means further work is needed before the method can be broadly standardized and implemented across forensic laboratories.
It is also important to understand that this is a specialized laboratory analysis, not a commercially available home-testing kit or a simple device that can instantly identify a drug in someone’s drink.
The Discovery Could Also Help Investigate Suspicious Deaths
Beyond sexual assault and robbery investigations, researchers believe GHB-pentose could eventually help forensic specialists examine unexplained deaths.
The reason involves a particular challenge in postmortem toxicology.
GHB can occur naturally in the body and may also be produced after death.
Consequently, finding GHB in a deceased individual does not always establish whether the substance was consumed before death.
The research team examined urine samples from deceased individuals to investigate whether GHB-pentose could help distinguish previous ingestion from postmortem GHB formation.
Among 20 urine samples from deceased individuals, researchers found elevated GHB levels but no detectable GHB-pentose.
In four additional samples, both substances were detected.
The results suggest that GHB-pentose may provide useful information when determining whether GHB was ingested before death.
Researchers nevertheless stressed that additional investigations are required before this potential application can be considered conclusive.
What Other International News Outlets Are Reporting
The discovery has attracted attention from international media organizations because of its potential implications for forensic investigations.
Reuters and AFP-distributed international reporting: Coverage of the research has highlighted the potential 72-hour detection window and the importance of identifying GHB exposure after conventional testing becomes less effective.
The Local Switzerland: Its November 11 report explained how the University of Zurich’s biomarker could improve the detection of GHB in urine and discussed the 2,414 forensic samples examined by researchers.
Swissinfo: Its November 10 coverage emphasized the potential value of the biomarker in suspected criminal cases and unexplained deaths, while noting that further investigation is needed.
RTÉ News: The Irish broadcaster also reported on the Swiss discovery, explaining how the extended detection window could assist sexual assault investigations.
Medical Xpress: Its November 10 research coverage provided additional scientific details, including the 21 GHB-positive samples, the 14 cases with detectable GHB-pentose despite low GHB levels and the possible application in postmortem investigations.
Together, these reports reinforce the importance of the discovery while emphasizing that it remains a developing forensic technique rather than a universal solution to drug-facilitated crime investigations.
Not Just GHB: Other Substances Can Also Be Used in Drug-Facilitated Assault
Although the Swiss discovery focuses specifically on GHB, it is important to recognize that GHB is not the only substance associated with drug-facilitated sexual assault.
Other substances, including certain benzodiazepines and ketamine, can also impair consciousness, judgment and memory.
Alcohol can also be involved, whether consumed voluntarily or administered without someone’s knowledge.
These substances have different chemical properties and detection windows.
The GHB-pentose discovery should therefore not be interpreted as a universal method for detecting every drug used in drink-spiking incidents.
It specifically concerns previous GHB exposure.
Other substances require appropriate toxicological testing and laboratory methods suited to their chemical characteristics.
This distinction is important for investigators and medical professionals when selecting the appropriate tests.
What Should Someone Do if They Suspect They Were Drugged?
The extended detection window may provide additional opportunities for forensic evidence collection, but individuals should never delay seeking medical attention because of the new research.
If someone suspects that a drink was spiked or that a substance was administered without their knowledge, obtaining medical assistance as soon as possible remains important.
Medical professionals can assess symptoms, provide appropriate treatment and determine whether toxicological testing or a forensic examination is necessary.
Some practical steps include:
- Seek medical attention immediately. GHB can cause serious complications, including unconsciousness and breathing difficulties. Severe symptoms require emergency care.
- Tell medical professionals what you remember. Explain when the suspected incident happened, what was consumed and any unusual symptoms or memory gaps.
- Ask about forensic toxicology testing. Explain that GHB exposure is suspected so medical and forensic personnel can consider appropriate blood and urine testing.
- Do not assume it is too late to seek help. Even when conventional testing may no longer detect GHB, newer biomarker testing could provide additional investigative possibilities where available.
- Preserve relevant evidence when possible. Messages, receipts, clothing and information about the location and timeline may assist an investigation. Do not put yourself at risk to collect evidence.
- Seek support from someone you trust. A suspected assault can be frightening and confusing. Medical professionals and victim-support services can help explain available options.
Importantly, a person does not need to remember every detail of an incident to deserve medical care or support.
The responsibility for drugging or assaulting another person always belongs to the perpetrator.
What Happens Next for the Swiss Discovery?
The latest study represents an important step toward improving the forensic detection of GHB exposure.
However, researchers still need to establish how reliably the biomarker performs across different individuals and circumstances.
Important questions remain:
- How consistently can GHB-pentose be detected at different intervals after ingestion?
- How do individual biological differences affect the results?
- Can laboratories establish standardized testing procedures?
- When will commercially available reference standards become available?
- How widely can the method be introduced into forensic laboratories internationally?
The University of Zurich’s existing use of the analysis demonstrates that the technique is already being applied in specialized forensic practice.
But wider adoption will require further validation, laboratory standardization and access to appropriate analytical resources.
The research team’s findings have been published in Drug Testing and Analysis under the title “Further extensive evaluation of GHB-pentose as a novel biomarker for the extended detection of GHB intake/administration in forensic casework.”
The paper was published on November 5, 2026.
The Bottom Line: A Longer Detection Window Could Give Investigators More Time to Find Evidence
The Swiss research offers a promising development in the fight against drug-facilitated crimes.
By identifying GHB-pentose in urine, forensic specialists may be able to detect previous GHB exposure even after conventional testing can no longer identify the original substance.
The potential 72-hour detection window could provide additional opportunities to investigate suspected assaults, robberies and unexplained deaths.
For victims, the discovery could eventually help address one of the most frustrating challenges in these cases: losing valuable forensic evidence simply because too much time has passed.
But the breakthrough must be understood within its scientific limitations.
It cannot independently prove an assault, establish consent, identify a perpetrator or replace a comprehensive investigation.
Further research and broader laboratory validation remain necessary.
Still, the discovery offers an important possibility: a substance that was once exceptionally difficult to detect after a short period may no longer leave investigators with such a narrow window to find evidence.
And as forensic science continues to improve, could this be the breakthrough that helps more victims have their experiences investigated with stronger scientific evidence?
